Her2-positive breast cancer: updating current best practice
Program Overview
Case #1: Neoadjuvant Setting
Case #1: Treatment Recommendations
NeoSphere: Study Design and pCR Results
PFS: All Arms of Therapy, ITT Population Time From Randomization to Progressive Disease, Disease Recurrence, or Death
TRYPHAENA: Cardiac Tolerability During the Study in the Safety Period
DFS: All Arms of Therapy, ITT Population Time From Date of Surgery to Disease Progression or Death
Case #2: Adjuvant Setting
Case #2: Treatment Recommendations
Adjuvant Paclitaxel and Trastuzumab: Phase 2 Data
Case #3: Advanced First-Line
PERUSE: First-line Pertuzumab, Trastuzumab Plus Investigator’s Choice of Taxane Therapy
Case #4: Second-Line Metastatic
Case #3: Treatment Considerations
Case #4: Second-Line Metastatic — Case Evolution
Case #4: Second-Line Metastatic — Case Evolution
EMILIA: CNS Metastases at Baseline and Progression
Abbreviations
Abbreviations
Abbreviations
Abbreviations